Introduction
Flap endo/exonuclease-1 (FEN-1), a structure specific nuclease, cleaves the double strand-single strand junction of 5'-branched DNA, called a DNA flap structure, and also possesses 5' 3' exonuclease activity with a specificity for double stranded DNA containing nick or 5'-recessed ends (Harrington and Lieber, 1994a) . It has been proposed that DNA flap structures exist in vivo as intermediates during DNA replication, DNA repair and homologous DNA recombination (Pont-Kingdon et al., 1993; Tu r c h i et al., 1994) .
The nucleotide sequence of FEN-1 is highly homologous to the RAD2 gene family such as the human Xeroderma Pigmentosum complementation group G (XPG), S. cerevisiae R A D 2, S. cerevisiae YKL510 and S. pombe rad13, which are required for nucleotide excision repair (Prakash et al., 1993; Harrington and Lieber, 1994b; Murray et al ., 1994) . Therefore, it has been hypothesized that FEN-1 participates in the DNA repair mechanism.
Recently, it has been shown that FEN-1 is the same enzyme as maturation factor-1 (MF-1) (Hiraoka et al. , 1995) which is one of the components necessary for SV40 DNA replication in vitro ( Waga et al., 1994) . In addition, FEN-1 shows significant DNA sequence homology (Shen et al., 1996) and similar enzyme activity (Turchi and Bambara, 1993) to the 5' 3' exonuclease domain in E. coli DNA polymerase I, that also belongs to the structure-specific nucleases family (Lyamichev et a l., 1993) . A bovine analogue of human FEN-1 has been detected in highly purified fractions of DNA polymerase ε, and is required for Okazaki fragments processing during lagging strand DNA synthesis (Bambara et al. , 1997) .
Taken together, it has been proposed that FEN-1 is an eukaryotic counterpart to the 5' 3' exonuclease domain in prokaryotic DNA polymerase, and plays an important role in DNA replication, repair and recombination. However, to date there is no study showing the gene expression of FEN-1 in specific cell cycle stages. In this paper, the gene expression of human FEN-1 was analyzed during the cell cycle and cell cycle exit phase using HL-60 cells in different growth conditions.
Materials and Methods

Materials
Hydroxyurea, nocodazole, dimethylsulfoxide (DMSO), a l l -t r a n s retinoic acid (RA), 12-O-t e t r a d e c a n o y l p h o r b o l -13-acetate (TPA), phenylmethylsulfonyl fluoride (PMSF), trypsin inhibitor, leupeptin, antipain and propidium iodide were purchased from Sigma Chem. Co. (St. Louis, MO). DNase-free RNase was obtained from Boehringer Mannheim (Mannheim, Germany). Ni 2+ -Sepharose gel was purchased from Invitrogen Co. (Carlsbad, CA). All other chemicals used in the study were of reagent grade.
Cell culture and synchronization
The HL-60 and NIH-3T3 cells were obtained from American Type Culture Collection (Rockville, MD) and grown in RPMI 1640 medium supplemented with 10% heatinactivated fetal bovine serum at 37˚C in a humidified atmosphere of 5% CO 2 .
To synchronize cells at the G1 phase, the HL-60 cells were seeded at a density of 1 10 5 /ml and hydroxyurea was added to a final concentration of 1 mM. The cells were then incubated for 12 h at 37˚C in CO 2 -incubator. For preparing G2/M-arrested cells, the cells were treated with 0.1 µg/ml nocodazole for 16 h.
Flow cytometry analysis
Exponentially proliferating HL-60 cells and cell cyclearrested cells were washed with PBS twice, fixed in cold 70% ethanol, and stored at 4˚C. After 2 days, the cells were resuspended in 1 ml of PBS containing DNasefree RNase A (40 u/ml) and propidium iodide (50 µg/ml). Following a 45 min agitated incubation at room temperature, the amount of propidium iodide incorporation was determined using a flow cytometer (Coulter Epics Profile II, Hialeah, FL) (Logan et al., 1995) Induction of differentiation HL-60 cells (1 1 0 5 /ml) were seeded in a medium containing DMSO (1.3%), RA (1 µM) or TPA (100 nM), and then cultured at 37˚C in a 5% CO 2 -incubator for 5 days (TPA) or 7 days (DMSO and RA). Differentiation of cells was evaluated by morphological changes.
Preparation of anti-FEN-1 antibody
For protein overexpression, the DE3 cells (E. coli strain BL21) transformed by pET-FCH plasmid containing human FEN-1 cDNA were kindly donated by Dr. Park (Los Alamos Natl. Lab., NM). The recombinant FEN-1 protein was purified by passing the supernatant of the DE3 cell lysates over a Ni 2 + -Sepharose column under nondenaturing conditions.
The antibody for western blot analysis was prepared by immunizing rabbits with the purified recombinant hFEN-1 protein.
Western blot analysis
The synchronized cells were washed with PBS twice, and then lysed in RIPA buffer (50 mM Tris, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 100 µg/ml trypsin inhibitor, 50 µM leupeptin, 100 µM antipain; pH 8.0) . After determining protein concent-ration of each lysate, equal amounts of the samples were loaded on a 12.5% SDS-polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane and analyzed with the anti-hFEN-1 antibody using an enhanced chemiluminescence detection kit (Amersham, Bucking-hamshire, U.K.).
Northern blot analysis
Total cellular RNAs were isolated from HL-60 cells treated with or without various reagents. six µg of the each RNA sample were electrophoresed on 1% agarose-formaldehyde gel and transferred to a nylon membrane. FEN-1 mRNA was analyzed by the DIG chemiluminescence detection method according to the procedure recommended by the manufacturer (Boehringer Mannheim, Mannheim, Germany). The probes incorporated with DIG-11-dUTP were prepared by PCR amplification (606 -940 bp region of human FEN-1 cDNA).
Results and Discussion
Gene expression of FEN-1 during cell proliferation
It has been shown that FEN-1 is an important component for DNA replication (Bambara et al., 1997) , and that several proteins acting in DNA replication, such as DNA polymerase α, proliferating cell nuclear antigen (PCNA), and DNA ligase, are inducible during cell proliferation (Wahl et al., 1988; Montecucco et al., 1992; Moore and Wang, 1994) . In order to examine whether FEN-1 could also be induced during cell proliferation, FEN-1 gene expression was analyzed in specific cell cycle stages and during cell cycle exit.
For synchronizing in G1 and G2/M phases, HL-60 promyelocytic leukemia cells were incubated with 1 mM of hydroxyurea for 12 h and 0.1 µg/ml of nocodazole for 16 h, respectively. After incubation, the DNA contents of the cells were analyzed using a flow cytometer. As shown in Figure 1A , more than 80% of the hydroxyurea-treated cells arrested at G1 and about 70% of the nocodazoltreated cells arrested at G2/M. When the HL-60 cells were incubated with 0.1 µg/ml of nocodazole for 16 h, some cells died because of the toxicity of this reagent. It is likely that the cell population having a low DNA content shown in Figure 1Ac corresponds to the dead cells. As it is difficult to get cells in the S phase only, exponentially growing HL-60 cells (log-phase cells) were used instead of cells synchronized in the S phase (cells synthesizing DNA).
Total RNAs were isolated from G1 and G2/M-arrested HL-60 cells as well as exponentially growing cells. The FEN-1 mRNA level was checked by northern blot analysis using a human FEN-1 specific probe labeled with DIG. Not only log-phase HL-60 cells, but also G1 or G2/M-arrested cells exhibited FEN-1 gene expression, but the mRNA level was higher in exponentially growing cells than in growth-arrested cells ( Figure 1B) . The protein levels in growing and temporarily growth-arrested cells showed similar patterns to the mRNA levels ( Figure 1C) .
After NIH-3T3 mouse fibroblast cells were growtharrested at the G1 stage by serum starvation, the cells reentered the mitotic cell cycle following serum stimulation. As shown in Figure 2 , a sharp increase of the FEN-1 protein resulted from the induction of entry into the S phase of G1-arrested NIH-3T3 cell.
These results show that FEN-1 is up-regulated during cell proliferation, and shows a similar pattern to other DNA replication proteins, such as DNA polymerase α a n d DNA ligase, which are also inducible in cell proliferation (Wahl et al., 1988; Montecucco et al., 1992; Moore and Wang, 1994) .
Induction of differentiation of HL-60 cells
It was discussed as to whether FEN-1 gene expression could be down-regulated in non-growing cells which had exited the cell cycle permanently. It has been well established that HL-60 promyelocytic leukemia cells could be induced through terminal differentiation into granulocytes or macrophages by DMSO, RA or TPA, respectively, and so HL-60 cells were incubated with 1.3% DMSO or 1 µM RA for 7 days, or with 100 nM TPA for 5 days in order to prepare nongrowing human leukemia cells. After incubation, cell differentiation was evaluated by observing morphological changes of the cells. Nuclei of DMSO- and RA-treated cells were similar to that of granulocytes showing bending and segregated nuclei, while TPA -t r e a t e d cells had a decreased nucleus/cytosol ratio contrast compared to untreated control cells in Giemsa staining ( Figure 3A) . The TPA-treated cells also adhered to the bottom of the culture dish. These results indicate that HL-60 cells were well differentiated into granulocytes or macrophages by DMSO, RA, or TPA.
Down-regulation of FEN-1 gene expression in differentiated HL-60 cells
Human FEN-1 gene expression in differentiated HL-60 cells was analyzed by the northern blot method. As shown in Figure 3B , HL-60 cells differentiated into granulocytes by DMSO and RA showed a remarkable decline in FEN-1 gene expression, 30% and 20% respectively, to the control mRNA level. Specifically, FEN-1 mRNA was not detectable in HL-60 cells treated with TPA for 5 days. These results demonstrate that human FEN-1 gene expression is substantially down-regulated at the mRNA level during cell differentiation, suggesting that human FEN-1 parti-cipates in cell proliferation.
In this study, to identify FEN-1 as a DNA replication protein, human FEN-1 gene expression was examined in actively growing and nongrowing human promyelocytic leukemia cells. Data indicates that human FEN-1 gene is up-regulated during entry into the S phase of G1-arrested cells, and down-regulated in nongrowing cells.
Also, recent studies have demonstrated that FEN-1 is an important enzyme for DNA replication. i . e . , i )
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FEN-1 gene expression
Mutant cells lacking in yeast FEN-1 gene showed deficient cell growth (Johnson et al., 1995) . ii) Ye a s t FEN-1 interacted with a replicative helicase (Budd and Campbell, 1997) as well as PCNA (Li et al., 1995) which is the accessory factor for DNA polymerases δ and ε. iii) Calf FEN-1 homo-logy was copurified with calf DNA polymerase ε (Bambara et al., 1997) . iv) Bovine FEN-1 acted in the removal of RNA primer during Okazaki fragment maturation (Bambara et al., 1997) .
Together with data from these experiments and other researchers' data, it seems likely that FEN-1 gene expression is induced during cell proliferation to play a role in DNA replication. These facts suggest that FEN-1 may be applied as a useful new tumor marker, the work is now in progress. 
